Impact of neoadjuvant chemotherapy on survival in breast cancer patients in daily practice: a population-based study.
暂无分享,去创建一个
P. Maingon | P. Arveux | P. Fumoleau | A. Arnaud | F. Bonnetain | L. Arnould | G. Créhange | T. S. Dabakuyo | M. Poillot | B. Coudert | S. Causeret
[1] D. Doval,et al. Neoadjuvant chemotherapy in breast cancer: review of literature. , 2013, Journal of the Indian Medical Association.
[2] A. Jemal,et al. Global Cancer Statistics , 2011 .
[3] G. Hédelin,et al. Population-based study of breast cancer survival in Cote d'Or (France): prognostic factors and relative survival. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.
[4] J. Ioannidis,et al. RESPONSE: Re: Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis , 2005 .
[5] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[6] J. Ioannidis,et al. Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis. , 2005, Journal of the National Cancer Institute.
[7] A. Awada,et al. Primary chemotherapy for breast cancer: the evidence and the future. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[8] Paul W Dickman,et al. Regression models for relative survival , 2004, Statistics in medicine.
[9] B. Asselain,et al. Short and long‐term effects on survival in breast cancer patients treated by primary chemotherapy: an updated analysis of a randomized trial , 1999, Breast Cancer Research and Treatment.
[10] D. Wickerham,et al. The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] Donald L Weaver,et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] Fiona J Gilbert,et al. Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] C. V. D. van de Velde,et al. Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] G. MacGrogan,et al. Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonié Bordeaux Groupe Sein (IBBGS). , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.
[15] D. Tripathy,et al. Tamoxifen for early breast cancer: An overview of the randomised trials , 1999 .
[16] Anna L. Brown,et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] H. Bear. Indications for neoadjuvant chemotherapy for breast cancer. , 1998, Seminars in Oncology.
[18] B. Leone,et al. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma. , 1998, The cancer journal from Scientific American.
[19] G. Bonadonna,et al. Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] D. Wickerham,et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] G. Bonadonna,et al. Primary chemotherapy in operable breast cancer. , 1996, Seminars in oncology.
[22] D. G. Altman,et al. Review of survival analyses published in cancer journals. , 1995, British Journal of Cancer.
[23] T. Powles,et al. Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] G. Calais,et al. Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm , 1994, Cancer.
[25] B. Asselain,et al. Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6. , 1994, European journal of cancer.
[26] G. Hortobagyi,et al. Feasibility of breast‐conservation surgery after induction chemotherapy for locally advanced breast carcinoma , 1992, Cancer.
[27] B. Asselain,et al. Neoadjuvant chemotherapy in operable breast cancer. , 1991, European journal of cancer.
[28] L. Mauriac,et al. Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre. , 1991, Annals of oncology : official journal of the European Society for Medical Oncology.
[29] B. Asselain,et al. Neoadjuvant chemotherapy in operabla breast cancer , 1991 .
[30] G. Hortobagyi,et al. Comprehensive management of locally advanced breast cancer , 1990, Cancer.
[31] G. Hortobagyi,et al. Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy , 1988, Cancer.
[32] L. Sobin,et al. TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.
[33] G. Hortobagyi,et al. Multimodal treatment of locoregionally advanced breast cancer , 1983, Cancer.
[34] W. McGuire,et al. The value of estrogen and progesterone receptors in the treatment of breast cancer , 1980, Cancer.